
|Videos|December 10, 2014
Concerns Over Drug Interaction Alert Fatigue
Daniel C. Malone, RPh, PhD, FAMCP, defines drug interaction alert fatigue.
Advertisement
Daniel C. Malone, RPh, PhD, FAMCP, a professor of pharmacy at the University of Arizona College of Pharmacy, defines drug interaction alert fatigue.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA, HHS Move to Accelerate Biosimilar Approvals
2
Accelerated Approval of Cancer Drugs: Benefit or Burden?
3
Pharmacists Lead the Way in Evolving CAR T-Cell and Bispecific Antibody Therapy Management
4
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
5

















































































































































































































